Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXA3
|
ENSG00000170608.2 | forkhead box A3 |
FOXC2
|
ENSG00000176692.4 | forkhead box C2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_46367785_46367936 | FOXA3 | 342 | 0.730898 | -0.63 | 6.8e-02 | Click! |
chr19_46368095_46368246 | FOXA3 | 652 | 0.493263 | -0.49 | 1.8e-01 | Click! |
chr19_46367218_46367373 | FOXA3 | 48 | 0.912787 | -0.41 | 2.7e-01 | Click! |
chr16_86597747_86598117 | FOXC2 | 2925 | 0.202941 | -0.55 | 1.2e-01 | Click! |
chr16_86599676_86600071 | FOXC2 | 984 | 0.422162 | 0.48 | 1.9e-01 | Click! |
chr16_86600319_86600625 | FOXC2 | 385 | 0.712209 | -0.48 | 1.9e-01 | Click! |
chr16_86600905_86601272 | FOXC2 | 231 | 0.544631 | -0.21 | 5.9e-01 | Click! |
chr16_86599336_86599535 | FOXC2 | 1422 | 0.320431 | -0.14 | 7.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_65042904_65043175 | 0.69 |
POLA2 |
polymerase (DNA directed), alpha 2, accessory subunit |
6939 |
0.14 |
chr17_26673764_26673915 | 0.67 |
TNFAIP1 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
6407 |
0.07 |
chr5_143302241_143302392 | 0.64 |
HMHB1 |
histocompatibility (minor) HB-1 |
110590 |
0.07 |
chr12_29895057_29895338 | 0.62 |
TMTC1 |
transmembrane and tetratricopeptide repeat containing 1 |
41534 |
0.21 |
chr10_115910998_115911149 | 0.62 |
C10orf118 |
chromosome 10 open reading frame 118 |
6712 |
0.18 |
chr10_79669456_79669735 | 0.61 |
ENSG00000243446 |
. |
2709 |
0.24 |
chr13_33803306_33803457 | 0.60 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
23238 |
0.2 |
chr12_66089003_66089154 | 0.59 |
HMGA2 |
high mobility group AT-hook 2 |
128833 |
0.05 |
chr10_95507444_95507712 | 0.59 |
LGI1 |
leucine-rich, glioma inactivated 1 |
9988 |
0.23 |
chr9_127457299_127457545 | 0.54 |
ENSG00000207737 |
. |
1433 |
0.34 |
chr6_139697731_139697996 | 0.51 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
2106 |
0.42 |
chr7_41909334_41909592 | 0.50 |
AC005027.3 |
|
164530 |
0.04 |
chr4_89712910_89713251 | 0.49 |
FAM13A |
family with sequence similarity 13, member A |
31272 |
0.18 |
chr3_37156478_37156973 | 0.48 |
ENSG00000206645 |
. |
22000 |
0.14 |
chr11_12147194_12147407 | 0.47 |
MICAL2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
4278 |
0.32 |
chr1_226001199_226001845 | 0.46 |
EPHX1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
3686 |
0.18 |
chr8_81837852_81838134 | 0.46 |
ZNF704 |
zinc finger protein 704 |
50977 |
0.17 |
chr1_68218070_68218221 | 0.46 |
ENSG00000238778 |
. |
20191 |
0.2 |
chr6_42192050_42192201 | 0.46 |
MRPS10 |
mitochondrial ribosomal protein S10 |
6522 |
0.19 |
chr1_200142035_200142186 | 0.46 |
ENSG00000221403 |
. |
28148 |
0.23 |
chr10_17255993_17256144 | 0.45 |
TRDMT1 |
tRNA aspartic acid methyltransferase 1 |
12218 |
0.15 |
chr5_65169471_65169622 | 0.45 |
ERBB2IP |
erbb2 interacting protein |
52757 |
0.14 |
chr3_54925868_54926132 | 0.45 |
CACNA2D3-AS1 |
CACNA2D3 antisense RNA 1 |
9282 |
0.27 |
chr12_26899774_26900056 | 0.44 |
ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
85799 |
0.09 |
chr5_37831903_37832054 | 0.44 |
GDNF |
glial cell derived neurotrophic factor |
3032 |
0.32 |
chr6_167011503_167011887 | 0.44 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
29030 |
0.2 |
chr19_6745452_6745603 | 0.43 |
TRIP10 |
thyroid hormone receptor interactor 10 |
4598 |
0.13 |
chr2_75052279_75052565 | 0.43 |
HK2 |
hexokinase 2 |
8686 |
0.26 |
chr12_57542255_57543089 | 0.43 |
RP11-545N8.3 |
|
1270 |
0.29 |
chr12_51328994_51329173 | 0.42 |
ENSG00000199740 |
. |
4726 |
0.16 |
chr16_53809610_53810340 | 0.42 |
FTO |
fat mass and obesity associated |
71881 |
0.11 |
chr8_18815764_18816021 | 0.42 |
ENSG00000201157 |
. |
21237 |
0.2 |
chr21_40017078_40017229 | 0.42 |
ERG |
v-ets avian erythroblastosis virus E26 oncogene homolog |
15438 |
0.29 |
chr18_32353571_32353898 | 0.41 |
RP11-138H11.1 |
|
6107 |
0.24 |
chr7_92382094_92382391 | 0.40 |
ENSG00000206763 |
. |
51114 |
0.14 |
chr12_66050940_66051359 | 0.40 |
HMGA2 |
high mobility group AT-hook 2 |
166762 |
0.03 |
chr8_122761217_122761368 | 0.40 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
107616 |
0.07 |
chr8_119427422_119427697 | 0.39 |
AC023590.1 |
Uncharacterized protein |
133078 |
0.05 |
chr3_10018102_10018700 | 0.39 |
EMC3 |
ER membrane protein complex subunit 3 |
9965 |
0.08 |
chr1_85192628_85192779 | 0.39 |
SSX2IP |
synovial sarcoma, X breakpoint 2 interacting protein |
36217 |
0.17 |
chr6_128828935_128829086 | 0.39 |
RP1-86D1.4 |
|
2740 |
0.23 |
chr2_19105426_19105685 | 0.39 |
NT5C1B |
5'-nucleotidase, cytosolic IB |
334717 |
0.01 |
chr12_109245220_109245638 | 0.38 |
SSH1 |
slingshot protein phosphatase 1 |
5930 |
0.16 |
chr12_680792_680943 | 0.38 |
RP5-1154L15.2 |
|
14785 |
0.13 |
chr16_49733508_49733659 | 0.38 |
ENSG00000221134 |
. |
20452 |
0.22 |
chr10_5987028_5987378 | 0.38 |
RP11-536K7.3 |
|
498 |
0.76 |
chr6_113955614_113956033 | 0.38 |
ENSG00000266650 |
. |
31706 |
0.2 |
chr3_149015625_149015955 | 0.37 |
RP11-206M11.7 |
|
13221 |
0.19 |
chr22_28627219_28627370 | 0.37 |
ENSG00000201209 |
. |
1517 |
0.52 |
chr4_102227546_102228201 | 0.37 |
ENSG00000221265 |
. |
23698 |
0.19 |
chr14_69016635_69017130 | 0.37 |
CTD-2325P2.4 |
|
78280 |
0.1 |
chr3_29388301_29388452 | 0.37 |
ENSG00000216169 |
. |
22536 |
0.22 |
chr16_71916526_71917374 | 0.36 |
ZNF821 |
zinc finger protein 821 |
462 |
0.56 |
chr5_55646712_55646863 | 0.36 |
ENSG00000210678 |
. |
53271 |
0.13 |
chr9_89989865_89990016 | 0.36 |
ENSG00000212421 |
. |
114575 |
0.06 |
chr14_52133403_52133554 | 0.35 |
FRMD6 |
FERM domain containing 6 |
14780 |
0.18 |
chr9_73192109_73192260 | 0.35 |
ENSG00000272232 |
. |
2193 |
0.43 |
chr1_10334763_10335048 | 0.35 |
ENSG00000199562 |
. |
24119 |
0.13 |
chr8_131377178_131377403 | 0.35 |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
21833 |
0.28 |
chr2_26919704_26919855 | 0.35 |
KCNK3 |
potassium channel, subfamily K, member 3 |
4160 |
0.2 |
chr9_86126228_86126614 | 0.35 |
FRMD3 |
FERM domain containing 3 |
26932 |
0.16 |
chr3_159542532_159542683 | 0.35 |
ENSG00000264146 |
. |
2123 |
0.28 |
chr11_95995991_95996601 | 0.35 |
ENSG00000266192 |
. |
78306 |
0.1 |
chr18_12336971_12337122 | 0.35 |
TUBB6 |
tubulin, beta 6 class V |
26080 |
0.14 |
chr12_65889411_65889562 | 0.34 |
MSRB3 |
methionine sulfoxide reductase B3 |
168831 |
0.03 |
chr4_96028568_96028719 | 0.34 |
BMPR1B |
bone morphogenetic protein receptor, type IB |
3137 |
0.41 |
chr1_31870789_31870940 | 0.34 |
SERINC2 |
serine incorporator 2 |
11548 |
0.15 |
chr1_43760092_43760243 | 0.34 |
TIE1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
6497 |
0.13 |
chr13_45769539_45769983 | 0.34 |
KCTD4 |
potassium channel tetramerization domain containing 4 |
909 |
0.6 |
chr3_187596980_187597131 | 0.34 |
BCL6 |
B-cell CLL/lymphoma 6 |
133540 |
0.05 |
chr14_59680322_59680595 | 0.34 |
DAAM1 |
dishevelled associated activator of morphogenesis 1 |
25041 |
0.26 |
chr1_95258755_95258906 | 0.34 |
SLC44A3 |
solute carrier family 44, member 3 |
27068 |
0.18 |
chr18_61497949_61498456 | 0.34 |
SERPINB2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
40724 |
0.14 |
chr18_18743331_18743728 | 0.34 |
ENSG00000251886 |
. |
43062 |
0.15 |
chr17_9784093_9784244 | 0.34 |
RCVRN |
recoverin |
24770 |
0.16 |
chr8_110241621_110241772 | 0.34 |
RP11-122A21.2 |
|
69131 |
0.11 |
chr10_75646701_75646885 | 0.33 |
CAMK2G |
calcium/calmodulin-dependent protein kinase II gamma |
12450 |
0.12 |
chr1_12483776_12483927 | 0.33 |
VPS13D |
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
13927 |
0.23 |
chr1_226456896_226457047 | 0.33 |
ENSG00000238545 |
. |
34992 |
0.12 |
chr2_68464884_68465350 | 0.33 |
ENSG00000216115 |
. |
8059 |
0.14 |
chr1_61803481_61803729 | 0.33 |
NFIA |
nuclear factor I/A |
14517 |
0.3 |
chr2_192128890_192129041 | 0.33 |
MYO1B |
myosin IB |
666 |
0.8 |
chr8_48345028_48345179 | 0.33 |
SPIDR |
scaffolding protein involved in DNA repair |
7860 |
0.3 |
chr20_18205406_18205557 | 0.33 |
ENSG00000266720 |
. |
34014 |
0.11 |
chr9_86937365_86937516 | 0.33 |
SLC28A3 |
solute carrier family 28 (concentrative nucleoside transporter), member 3 |
18158 |
0.24 |
chr20_52235971_52236462 | 0.33 |
ZNF217 |
zinc finger protein 217 |
10785 |
0.21 |
chr15_63142711_63142998 | 0.32 |
RP11-1069G10.1 |
|
6074 |
0.22 |
chr3_188374207_188374358 | 0.32 |
ENSG00000264114 |
. |
25792 |
0.18 |
chr8_30399265_30399682 | 0.32 |
CTD-2373N4.5 |
|
54958 |
0.13 |
chr10_31934113_31934264 | 0.32 |
ENSG00000222412 |
. |
110876 |
0.07 |
chr4_177927343_177927494 | 0.32 |
ENSG00000222859 |
. |
175178 |
0.03 |
chr16_18943732_18943883 | 0.32 |
ENSG00000265515 |
. |
2203 |
0.23 |
chr6_117813949_117814100 | 0.32 |
DCBLD1 |
discoidin, CUB and LCCL domain containing 1 |
10199 |
0.18 |
chr9_116336420_116336661 | 0.32 |
RGS3 |
regulator of G-protein signaling 3 |
6400 |
0.23 |
chr2_151348832_151348983 | 0.32 |
RND3 |
Rho family GTPase 3 |
4664 |
0.37 |
chr2_113969748_113969899 | 0.32 |
ENSG00000189223 |
. |
724 |
0.59 |
chr12_70381221_70381372 | 0.32 |
RP11-611E13.3 |
|
40435 |
0.18 |
chr5_127295498_127295826 | 0.32 |
SLC12A2 |
solute carrier family 12 (sodium/potassium/chloride transporter), member 2 |
123796 |
0.06 |
chr9_115947226_115947377 | 0.32 |
SLC31A2 |
solute carrier family 31 (copper transporter), member 2 |
34079 |
0.13 |
chr8_23192961_23193112 | 0.32 |
ENSG00000253837 |
. |
685 |
0.61 |
chr7_47521967_47522354 | 0.32 |
TNS3 |
tensin 3 |
1277 |
0.63 |
chr1_116665813_116666097 | 0.31 |
MAB21L3 |
mab-21-like 3 (C. elegans) |
11579 |
0.26 |
chr16_18980279_18980782 | 0.31 |
TMC7 |
transmembrane channel-like 7 |
14726 |
0.14 |
chr12_13025413_13025645 | 0.31 |
GPRC5A |
G protein-coupled receptor, family C, group 5, member A |
18187 |
0.14 |
chr5_33120670_33120821 | 0.31 |
CTD-2203K17.1 |
|
319980 |
0.01 |
chr4_122591083_122591234 | 0.31 |
ANXA5 |
annexin A5 |
26959 |
0.21 |
chr1_115876554_115876760 | 0.31 |
NGF |
nerve growth factor (beta polypeptide) |
4200 |
0.3 |
chr7_121601459_121601610 | 0.31 |
PTPRZ1 |
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
88119 |
0.09 |
chr4_160219446_160219597 | 0.31 |
ENSG00000216089 |
. |
2655 |
0.33 |
chr17_39158877_39159028 | 0.31 |
KRTAP3-2 |
keratin associated protein 3-2 |
2814 |
0.1 |
chr1_94095744_94095895 | 0.31 |
BCAR3 |
breast cancer anti-estrogen resistance 3 |
16165 |
0.21 |
chr20_19795785_19795937 | 0.31 |
AL121761.2 |
Uncharacterized protein |
57182 |
0.12 |
chr18_703347_703625 | 0.31 |
RP11-806L2.6 |
|
3037 |
0.14 |
chr2_12959099_12960371 | 0.31 |
ENSG00000264370 |
. |
82242 |
0.11 |
chr15_42869739_42870102 | 0.31 |
STARD9 |
StAR-related lipid transfer (START) domain containing 9 |
2063 |
0.24 |
chr12_7695771_7696015 | 0.31 |
CD163 |
CD163 molecule |
39404 |
0.15 |
chr14_78060038_78060870 | 0.30 |
SPTLC2 |
serine palmitoyltransferase, long chain base subunit 2 |
3210 |
0.25 |
chr9_110160402_110160553 | 0.30 |
ENSG00000263459 |
. |
35413 |
0.19 |
chr7_41046808_41047238 | 0.30 |
AC005160.3 |
|
231866 |
0.02 |
chr9_14273530_14273681 | 0.30 |
NFIB |
nuclear factor I/B |
34407 |
0.21 |
chr2_238365295_238365446 | 0.30 |
MLPH |
melanophilin |
28701 |
0.15 |
chr21_40203892_40204166 | 0.30 |
ETS2 |
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
22469 |
0.24 |
chr17_60868423_60868627 | 0.30 |
MARCH10 |
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
15476 |
0.23 |
chr6_17418790_17419045 | 0.30 |
CAP2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
24974 |
0.25 |
chr19_13128886_13129037 | 0.30 |
CTC-239J10.1 |
|
3636 |
0.12 |
chr6_150177550_150177701 | 0.30 |
RP11-350J20.12 |
|
4027 |
0.14 |
chr4_39616282_39616433 | 0.30 |
ENSG00000252796 |
. |
6275 |
0.19 |
chr2_150982564_150982715 | 0.30 |
RND3 |
Rho family GTPase 3 |
359257 |
0.01 |
chr7_76199541_76199736 | 0.30 |
AC004980.7 |
|
20703 |
0.16 |
chr4_54408278_54408429 | 0.30 |
LNX1 |
ligand of numb-protein X 1, E3 ubiquitin protein ligase |
16031 |
0.2 |
chr13_102164782_102164933 | 0.30 |
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
22554 |
0.27 |
chr7_23512466_23512617 | 0.30 |
IGF2BP3 |
insulin-like growth factor 2 mRNA binding protein 3 |
2455 |
0.25 |
chr2_151442887_151443038 | 0.29 |
RND3 |
Rho family GTPase 3 |
47437 |
0.2 |
chr13_24079029_24079180 | 0.29 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
65405 |
0.13 |
chr17_64541761_64541912 | 0.29 |
ENSG00000252685 |
. |
92553 |
0.07 |
chr21_47476154_47476305 | 0.29 |
AP001471.1 |
|
41215 |
0.11 |
chr2_216658765_216659109 | 0.29 |
ENSG00000212055 |
. |
84705 |
0.1 |
chr3_189655319_189655470 | 0.29 |
ENSG00000216058 |
. |
107683 |
0.07 |
chr9_97855804_97855955 | 0.29 |
ENSG00000207617 |
. |
7503 |
0.14 |
chr14_31926974_31927468 | 0.29 |
DTD2 |
D-tyrosyl-tRNA deacylase 2 (putative) |
505 |
0.5 |
chrX_136134760_136135069 | 0.29 |
GPR101 |
G protein-coupled receptor 101 |
21081 |
0.24 |
chr1_95155366_95155517 | 0.29 |
ENSG00000263526 |
. |
56015 |
0.15 |
chr16_70779927_70780078 | 0.29 |
RP11-394B2.6 |
|
958 |
0.42 |
chr15_67419351_67419566 | 0.29 |
SMAD3 |
SMAD family member 3 |
983 |
0.62 |
chr12_79803302_79803453 | 0.29 |
ENSG00000221788 |
. |
9660 |
0.22 |
chr4_95469001_95469152 | 0.29 |
PDLIM5 |
PDZ and LIM domain 5 |
24200 |
0.28 |
chr2_189847915_189848066 | 0.29 |
ENSG00000221502 |
. |
5172 |
0.24 |
chr14_71906567_71906777 | 0.29 |
ENSG00000242330 |
. |
8734 |
0.25 |
chr1_24621255_24621441 | 0.29 |
ENSG00000266511 |
. |
15003 |
0.15 |
chr10_95238712_95238863 | 0.29 |
MYOF |
myoferlin |
3164 |
0.24 |
chr2_204267089_204267240 | 0.28 |
ABI2 |
abl-interactor 2 |
11397 |
0.25 |
chr11_5627634_5627785 | 0.28 |
TRIM6 |
tripartite motif containing 6 |
9673 |
0.1 |
chr6_158838381_158838532 | 0.28 |
RP11-732M18.2 |
|
18863 |
0.2 |
chr20_52516714_52516865 | 0.28 |
AC005220.3 |
|
39910 |
0.19 |
chr2_40630418_40630569 | 0.28 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
26927 |
0.26 |
chr1_220959907_220960116 | 0.28 |
MARC1 |
mitochondrial amidoxime reducing component 1 |
90 |
0.97 |
chr1_230226034_230226185 | 0.28 |
GALNT2 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
23091 |
0.22 |
chr22_30578717_30578868 | 0.28 |
RP3-438O4.4 |
|
24306 |
0.13 |
chr3_30327250_30327403 | 0.28 |
ENSG00000199927 |
. |
18701 |
0.28 |
chr12_22886601_22886752 | 0.28 |
ETNK1 |
ethanolamine kinase 1 |
108385 |
0.07 |
chr3_137801461_137801643 | 0.28 |
DZIP1L |
DAZ interacting zinc finger protein 1-like |
15070 |
0.2 |
chr3_88859562_88859713 | 0.28 |
EPHA3 |
EPH receptor A3 |
297037 |
0.01 |
chr4_153278112_153278410 | 0.28 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
4138 |
0.26 |
chrX_7956062_7956321 | 0.28 |
PNPLA4 |
patatin-like phospholipase domain containing 4 |
60411 |
0.15 |
chr6_122116137_122116288 | 0.28 |
ENSG00000222659 |
. |
214545 |
0.02 |
chr11_43703429_43703844 | 0.28 |
HSD17B12 |
hydroxysteroid (17-beta) dehydrogenase 12 |
1305 |
0.56 |
chr11_20032738_20032889 | 0.28 |
NAV2 |
neuron navigator 2 |
11289 |
0.2 |
chr2_1635747_1635898 | 0.28 |
AC144450.1 |
|
11937 |
0.26 |
chr1_203614991_203615267 | 0.28 |
ATP2B4 |
ATPase, Ca++ transporting, plasma membrane 4 |
19201 |
0.22 |
chr6_16676788_16676939 | 0.28 |
RP1-151F17.1 |
|
84506 |
0.1 |
chr12_79097835_79097986 | 0.28 |
SYT1 |
synaptotagmin I |
159863 |
0.04 |
chr4_157700822_157700973 | 0.28 |
RP11-154F14.2 |
|
61614 |
0.13 |
chr8_38255858_38256009 | 0.28 |
LETM2 |
leucine zipper-EF-hand containing transmembrane protein 2 |
1442 |
0.28 |
chr20_32922542_32922693 | 0.27 |
AHCY |
adenosylhomocysteinase |
23009 |
0.13 |
chr11_36178088_36178239 | 0.27 |
COMMD9 |
COMM domain containing 9 |
132811 |
0.05 |
chr1_97850105_97850256 | 0.27 |
DPYD-IT1 |
DPYD intronic transcript 1 (non-protein coding) |
35517 |
0.24 |
chr13_37776493_37776644 | 0.27 |
ENSG00000202395 |
. |
35773 |
0.2 |
chr1_88109761_88109982 | 0.27 |
ENSG00000199318 |
. |
190815 |
0.03 |
chr14_75777038_75777189 | 0.27 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
30217 |
0.14 |
chr15_57441064_57441218 | 0.27 |
TCF12 |
transcription factor 12 |
70487 |
0.12 |
chr16_68692785_68692936 | 0.27 |
RP11-615I2.2 |
|
12789 |
0.13 |
chr1_85824713_85824864 | 0.27 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
45392 |
0.12 |
chr18_60548793_60548944 | 0.27 |
PHLPP1 |
PH domain and leucine rich repeat protein phosphatase 1 |
21515 |
0.2 |
chr2_159996273_159996501 | 0.27 |
ENSG00000202029 |
. |
112733 |
0.06 |
chr10_5662770_5662921 | 0.27 |
ENSG00000240577 |
. |
10581 |
0.18 |
chr11_47586327_47586794 | 0.27 |
PTPMT1 |
protein tyrosine phosphatase, mitochondrial 1 |
422 |
0.45 |
chr12_104400584_104400735 | 0.27 |
ENSG00000215976 |
. |
21770 |
0.12 |
chr4_174107791_174107942 | 0.27 |
RP11-10K16.1 |
|
17063 |
0.18 |
chr10_89917381_89917532 | 0.27 |
ENSG00000200891 |
. |
163004 |
0.04 |
chr4_187857949_187858100 | 0.27 |
ENSG00000252382 |
. |
79414 |
0.12 |
chr7_121170101_121170252 | 0.27 |
ENSG00000221690 |
. |
44632 |
0.19 |
chr7_73708985_73709149 | 0.27 |
CLIP2 |
CAP-GLY domain containing linker protein 2 |
5262 |
0.21 |
chr8_11741139_11741290 | 0.27 |
CTSB |
cathepsin B |
14257 |
0.16 |
chr9_94298712_94298863 | 0.27 |
ENSG00000266855 |
. |
99746 |
0.08 |
chr5_37739048_37739199 | 0.27 |
ENSG00000206743 |
. |
38584 |
0.18 |
chr15_82375309_82375460 | 0.27 |
RP11-597K23.2 |
Uncharacterized protein |
5590 |
0.22 |
chr11_12699502_12699653 | 0.27 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
2527 |
0.41 |
chr9_18481044_18481195 | 0.27 |
ADAMTSL1 |
ADAMTS-like 1 |
6888 |
0.31 |
chr4_157882994_157883145 | 0.27 |
PDGFC |
platelet derived growth factor C |
8986 |
0.23 |
chr2_66723693_66723844 | 0.27 |
MEIS1 |
Meis homeobox 1 |
12291 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.2 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.3 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.2 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.0 | 0.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.1 | GO:0072191 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.0 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.1 | GO:1903224 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.0 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.3 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.0 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:1901984 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.2 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.0 | GO:0060510 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.3 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.1 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.2 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:0071637 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.0 | 0.0 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 0.1 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.0 | 0.1 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.5 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.0 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.1 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.2 | GO:0048821 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.0 | 0.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.0 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.0 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.0 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.0 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.1 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.2 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.0 | GO:2000831 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.0 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.0 | 0.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.0 | GO:0060841 | venous blood vessel morphogenesis(GO:0048845) venous blood vessel development(GO:0060841) |
0.0 | 0.0 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.0 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.0 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.0 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.0 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.0 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.0 | 0.0 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.0 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.3 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.1 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.0 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.0 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.7 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.8 | GO:0030016 | myofibril(GO:0030016) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.2 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.1 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.3 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.0 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.0 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.0 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.0 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.0 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 1.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.0 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |